BETA DRUGS LTDBETA DRUGS LTDBETA DRUGS LTD

BETA DRUGS LTD

No trades
See on Supercharts
Market capitalization
‪13.03 B‬INR
‪307.19 M‬INR
‪2.27 B‬INR
‪1.77 M‬
Beta (1Y)
0.67

About BETA DRUGS LTD

Headquarters
Panchkula
Employees (FY)
315
Founded
2005
ISIN
INE351Y01019
FIGI
BBG00HVHP681
Beta Drugs Ltd. engages in the manufacturing and trading of pharmaceuticals. The firm focuses on manufacturing oncology and dermatology medicines. Its products include adside etoposide, adrea hydroxy urea, adcarb carboplatin, doxorubicin, and adben bendamustine. The company was founded by Vijay Kumar Batra, Inpeet Singh, and Gaganpeet Kaur on September 21, 2005 and is headquartered in Panchkula, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BETA is 1398.50 INR — it has increased by 1.34% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange BETA DRUGS LTD stocks are traded under the ticker BETA.
BETA stock is 1.89% volatile and has beta coefficient of 0.67. Check out the list of the most volatile stocks — is BETA DRUGS LTD there?
Yes, you can track BETA DRUGS LTD financials in yearly and quarterly reports right on TradingView.
BETA stock has risen by 5.95% compared to the previous week, the month change is a 13.24% rise, over the last year BETA DRUGS LTD has showed a 88.73% increase.
BETA net income for the last quarter is ‪198.73 M‬ INR, while the quarter before that showed ‪148.84 M‬ INR of net income which accounts for 33.52% change. Track more BETA DRUGS LTD financial stats to get the full picture.
Today BETA DRUGS LTD has the market capitalization of ‪13.27 B‬, it has increased by 1.13% over the last week.
No, BETA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BETA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BETA DRUGS LTD stock right from TradingView charts — choose your broker and connect to your account.
BETA reached its all-time high on Dec 15, 2023 with the price of 1595.00 INR, and its all-time low was 37.00 INR and was reached on Mar 25, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 315.00 employees. See our rating of the largest employees — is BETA DRUGS LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BETA DRUGS LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BETA DRUGS LTD stock shows the strong buy signal. See more of BETA DRUGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BETA DRUGS LTD EBITDA is ‪591.76 M‬ INR, and current EBITDA margin is 23.79%. See more stats in BETA DRUGS LTD financial statements.